Trial · NCT01116882
Outcomes17
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | 30-day Composite Major Adverse Cardiac Event (MACE) | 30 days | The denominator for MACE at 30 days is defined as patients who either had MACE to 30d or had follow up of at least 23 days. | participants | NUMBER |
| PRIMARY | 12-month Composite Major Adverse Cardiac Event (MACE) | 12 month | participants | NUMBER | |
| SECONDARY | All Cause Mortality at 30 Days | 30 days | The denominator for MACE at 30 days is defined as patients who either died to 30d or had follow up of at least 23 days. | participants | NUMBER |
| SECONDARY | Ischemia-driven Target Lesion Revascularization | 30 days | participants | NUMBER | |
| SECONDARY | Ischemia-driven Target Lesion Revascularization | 12 months | participants | NUMBER | |
| SECONDARY | Rate of Stent Thrombosis | 12 months | participants | NUMBER | |
| SECONDARY | Any Repeat Revascularization | 12 months | participants | NUMBER | |
| SECONDARY | Emergency or Urgent Revascularization | 30 days | The denominator for emergency or urgent revascularization at 30 days is defined as patients who either had the event to 30d or had follow up of at least 23 days. | participants | NUMBER |
| SECONDARY | Procedural Success | Post-Procedure | participants | NUMBER | |
| SECONDARY | Major Vascular Complications | 30 days | participants | NUMBER | |
| SECONDARY | Complete Revascularization | Post-Procedure | participants | NUMBER | |
| SECONDARY | Met Indication Criteria for PCI | Post-Procedure | lesions | NUMBER | |
| SECONDARY | All Cause Mortality at 12 Months | 12 months | participants | NUMBER | |
| SECONDARY | Ischemia-driven Target Vessel Revascularization | 30 days | participants | NUMBER | |
| SECONDARY | Ischemia-driven Target Vessel Revascularization | 12 months | participants | NUMBER | |
| SECONDARY | Rate of Stent Thrombosis | 30 days | participants | NUMBER | |
| SECONDARY | Any Repeat Revascularization | 30 days | The denominator for any repeat revascularization at 30 days is defined as patients who either had the event to 30d or had follow up of at least 23 days. | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01116882/outcomes